{"url":"https://newsforagent.com/news/2026-10-16/scholar-rock-inducement-grants-seven-hires","markdown_url":"https://newsforagent.com/news/2026-10-16/scholar-rock-inducement-grants-seven-hires.md","title":"Scholar Rock Grants 61,020 Inducement Shares to Seven Hires","headline":"Scholar Rock Grants 61,020 Inducement Shares to Seven Newly Hired Employees","description":"Scholar Rock granted 61,020 inducement shares to seven new hires, with options priced at $41.94, as the company commercializes ISEMBLYD for SMA.","section":"Leadership","published_at":"2026-10-16T20:54:20+00:00","modified_at":"2026-10-16T20:54:20+00:00","author":"News Desk","key_takeaways":["Scholar Rock granted inducement equity awards covering 61,020 shares to seven newly hired employees.","The awards consist of 17,461 stock options priced at $41.94 and 43,559 restricted stock units.","The grants were made under the company's 2022 Inducement Equity Plan, adopted on June 16, 2022."],"companies":[{"name":"Scholar Rock","is_primary":true,"profile_url":"https://akta.pro/company-profiles/0000dwq/scholar-rock","website":"http://scholarrock.com"}],"source":{"publisher":"Business Wire","title":"Scholar Rock grants awards covering 61,020 shares","url":"https://www.businesswire.com/news/home/20261016504258/en/"},"other_sources":[],"tags":["Leadership","Scholar Rock"],"body_markdown":"[Scholar Rock](https://akta.pro/company-profiles/0000dwq/scholar-rock) granted inducement equity awards covering 61,020 shares of common stock to seven newly hired employees, the company said on October 16, 2026. The awards consist of stock options to purchase 17,461 shares and restricted stock units covering 43,559 shares, according to [Business Wire](https://www.businesswire.com/news/home/20261016504258/en/).\n\n## Scholar Rock's Inducement Awards and Vesting Terms\n\nThe inducement stock options carry an exercise price of $41.94, equal to the closing price of Scholar Rock's common stock on October 12, 2026, according to akta.pro [company records](https://akta.pro/company-data). The options vest with respect to 25% of the underlying shares on the first anniversary of each employee's start date, with the remaining 75% vesting in 12 equal quarterly installments thereafter. The restricted stock units vest in four equal annual installments. All vesting is subject to the employees' continuing service at the company through the applicable vesting date.\n\nThe awards are subject to the terms of the company's 2022 Inducement Equity Plan, initially adopted by the board of directors on June 16, 2022. The plan is used exclusively for grants to individuals who were not previously employees of Scholar Rock, or following a bona fide period of non-employment, as an inducement material to entering employment with the company, pursuant to Nasdaq Listing Rule 5635(c)(4).\n\n## Scholar Rock's Commercialization of ISEMBLYD\n\nScholar Rock is commercializing ISEMBLYD (apitegromab-mstn) in the U.S. for people living with spinal muscular atrophy who are 2 years of age and older and currently receiving a survival motor neuron 2 (SMN2)-targeted treatment, following FDA approval in September 2026. The company plans to expand access to ISEMBLYD globally, in up to 50 countries worldwide.\n\n## Scholar Rock's Recent Inducement Grants\n\nScholar Rock granted inducement equity awards covering 83,102 shares to ten new employees on September 21, 2026, including 23,801 stock options and 59,301 restricted stock units, Yahoo reported. The awards were under the 2022 Inducement Equity Plan, with options exercisable at $51.85 and vesting over time.\n\nScholar Rock resubmitted the Marketing Authorisation Application for apitegromab to the European Medicines Agency for SMA treatment on October 8, 2026, replacing the Catalent Indiana facility with an alternate U.S. site, Stock Titan reported. The FDA granted Fast Track and Orphan Drug designations to apitegromab for facioscapulohumeral muscular dystrophy on September 2, 2026, with participant dosing underway in the Phase 2 FORGE trial, MarketScreener reported.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}